LONG TERM EFFICACY AND SAFETY OF INFLIXIMAB IN THE TREATMENT OF BEKET'S DISEASE

被引：0
|
作者：
Leccese, P. [1 ,2 ]
Latanza, L. [3 ]
Padula, A. [1 ,2 ]
Nigro, A. [1 ,2 ]
D'Angelo, S. [1 ,2 ]
Gilio, M. [1 ,2 ]
Palazzi, C. [4 ,5 ]
Olivieri, I. [1 ,2 ]
机构：
[1] San Carlo Hosp Potenza, Rheumatol Dept Lucania, Potenza, Italy
[2] Madonna delle Grazie Hosp Matera, Potenza, Italy
[3] Sect Ocular Immunopathol A Cardarelli Hosp, Dept Ophthalmol, Naples, Italy
[4] San Carlo Hosp Potenza, Rheumatol Dept Lucania, Matera, Italy
[5] Madonna delle Grazie Hosp Matera, Matera, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：638 / 638
页数：1
相关论文
共 50 条
  • [21] INFLIXIMAB LONG-TERM TREATMENT FOR UVEITIS IN BEHCET'S DISEASE
    Accorinti, Massimo
    Priori, Roberta
    Pirraglia, Maria Pia
    Paroli, Maria Pia
    Gattamelata, Angelica
    Mancini, Riccardo
    Spadaro, Antonio
    Pivetti-Pezzi, Paola
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S155 - S155
  • [22] Long-term efficacy and safety of golimumab in the treatment of multirefractory Behcet's disease
    Vitale, Antonio
    Emmi, Giacomo
    Lopalco, Giuseppe
    Fabiani, Claudia
    Gentileschi, Stefano
    Silvestri, Elena
    Gerardo, Di Scala
    Iannone, Florenzo
    Frediani, Bruno
    Galeazzi, Mauro
    Lapadula, Giovanni
    Rigante, Donato
    Cantarini, Luca
    CLINICAL RHEUMATOLOGY, 2017, 36 (09) : 2063 - 2069
  • [23] Long-term durability of Crohn's disease treatment with infliximab
    Rudolph, Stephen J.
    Weinberg, David I.
    McCabe, Robert P.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (04) : 1033 - 1041
  • [24] Infliximab in Crohn's disease: early and long-term treatment
    Armuzzi, A.
    De Pascalis, B.
    Fedeli, P.
    De Vincentis, F.
    Gasbarrini, A.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S271 - S279
  • [25] Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatment
    Waters, CH
    Kurth, M
    Bailey, P
    Shulman, LM
    LeWitt, P
    Dorflinger, E
    Deptula, D
    Pedder, S
    NEUROLOGY, 1997, 49 (03) : 665 - 671
  • [26] Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behcet's disease: a large-scale, long-term postmarketing surveillance in Japan
    Ohno, Shigeaki
    Umebayashi, Itsuro
    Matsukawa, Miyuki
    Goto, Takashi
    Yano, Toshiro
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [27] Double-dose infliximab therapy in Crohn's disease: appropriate time to evaluate the efficacy, long-term efficacy and safety
    Kunisaki, R.
    Nishio, M.
    Ogashiwa, T.
    Otake, H.
    Inoue, E.
    Kimura, H.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S327 - S328
  • [28] Long term safety of infliximab
    Schaible, TF
    PRESSE MEDICALE, 2001, 30 (12): : 610 - 613
  • [29] Long-Term Safety and Efficacy of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease
    Mock, Joseph D.
    Tuskey, Anne G.
    Rubin, Amy
    Behm, Brian W.
    GASTROENTEROLOGY, 2015, 148 (04) : S257 - S257
  • [30] Long-term efficacy and safety of infliximab in the treatment of patients affected by psoriasis and psoriatic arthritis
    Papoutsaki, M.
    Talamonti, M.
    Giunta, A.
    Costanzo, A.
    Chimenti, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 : 47 - 48
12345